NCAM1 and non-small cell lung carcinoma: In our cohort, EVs isolated from the plasma of NSCLC patients expressed several immune markers and we found down-modulation of CD56 and HLA-ABC in EVs from NR patients highlighting a potential impairment of NK cells in these patients.